scispace - formally typeset
M

Marcus Both

Researcher at University of Kiel

Publications -  79
Citations -  1730

Marcus Both is an academic researcher from University of Kiel. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 19, co-authored 61 publications receiving 1463 citations.

Papers
More filters
Journal ArticleDOI

Lack of efficacy of rituximab in Wegener’s granulomatosis with refractory granulomatous manifestations

TL;DR: B lymphocyte depletion was not associated with a change of the ANCA titres or obvious clinical improvement of refractory granulomatous disease in patients with WG in this pilot study.
Journal ArticleDOI

Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage?

TL;DR: There is evidence that locWG is a long-term disease stage or phenotype (5% of all patients with WG), 46% of whom are ANCA-positive, which is characterised by destructive and/or space-consuming lesions associated with high relapse rates and local damage.
Journal ArticleDOI

MRI of the lung (3/3)—current applications and future perspectives

TL;DR: New developments and future perspectives such as motion-compensated imaging with self-navigated sequences or fast Fourier decomposition MRI for non-contrast enhanced ventilation- and perfusion-weighted imaging of the lung are discussed.
Journal ArticleDOI

Giant Cell Arteritis: Diagnostic Accuracy of MR Imaging of Superficial Cranial Arteries in Initial Diagnosis—Results from a Multicenter Trial

TL;DR: MR imaging of superficial cranial arteries is accurate in the initial diagnosis of GCA giant cell arteritis and sensitivity probably decreases after more than 5 days of sCS systemic corticosteroid therapy; thus, imaging should not be delayed.
Journal ArticleDOI

MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis

TL;DR: MRI and PET are unreliable for assessing large-vessel inflammation in patients with giant cell arteritis and pre-existing immunosuppressive therapy, while MRI is valuable for its ability to detect morphological vessel lesions, such as aneurysms and stenoses.